Atlas Trials

Yifan Wang

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yifan Wang

RecordFirmDate
Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection (NCT07368803)Yifan Wang2025-09-11
The Cognitive Neural Mechanisms and Neuroregulatory Interventions of Realistic Creative Problem-solving Under the Effects of Drug Addiction (NCT06917534)Yifan Wang2023-11-23

Track Yifan Wang automatically

Every clearance here is in the API, with alerts when new ones post.